Serodus ASA Stock

Stocks

03/01/17	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
08/12/16	Serodus : Q&A delisting from Oslo Axess	PU
23/11/16	Serodus : Extraordinary general meeting held	PU
23/11/16	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
02/11/16	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	01/01/2023
Henrik Mordhorst DFI	Director of Finance/CFO	-	01/10/2019
Daniel Capion PRN	Corporate Officer/Principal	-	01/01/2021

Director	Title	Age	Since
Søren Elmann Ingerslev CHM	Chairman	-	01/01/2017
Terri Sebree BRD	Director/Board Member	68	01/04/2014
Viggo Gunnersen Harboe BRD	Director/Board Member	80	01/01/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	-0.25%	-4.10%	+38.38%	+92.61%	68.21B
ARGENX SE	+1.21%	+0.80%	+46.29%	+85.32%	64.25B
INSMED INCORPORATED	-0.25%	-1.92%	-10.72%	+436.70%	26.54B
BIONTECH SE	+0.33%	-10.61%	+1.95%	-16.27%	25.61B
GENMAB A/S	+1.18%	-2.23%	+30.87%	-19.04%	19.88B
PHARMAESSENTIA CORPORATION	-6.09%	-12.08%	+226.11%	+375.00%	17.13B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.61%	-5.63%	-1.48%	+532.58%	14.93B
EXELIXIS, INC.	+4.12%	+0.30%	+52.03%	+150.18%	14.1B
MADRIGAL PHARMACEUTICALS, INC.	-0.24%	+5.18%	+23.04%	+190.97%	12.45B
Average	-0.53%	-3.92%	+45.16%	+203.12%	29.23B
Weighted average by Cap.	+0.16%	-3.22%	+41.21%	+157.60%

Employees

Sector